Table 3 Analysis of haematological markers using one-way ANOVA with Tukey’s multiple comparison test
| Haematological marker (normal reference range) | Control mean (std. dev) [range] {% in normal range} | HIV negative-DVT mean (std. dev) [range] {% in normal range} | HIV positive-DVT mean (std. dev) [range] {% in normal range} | P value | Significant difference < 0.05 | ||
|---|---|---|---|---|---|---|---|
| Control vs. HIV negative-DVT | Control vs. HIV positive-DVT | HIV negative-DVT vs. HIV positive-DVT | |||||
| RCC (M: 4.2–5.9 × 1012/L F: 3.9–5.4 × 1012/L) | 5.3 (0.4) [4.5–5.8] {90.0} | 4.3 (0.9) [2.19–6.98] {65.7} | 3.7 (0.7) [2.5–5.0] 33.3} | 0.0003 | Yes | Yes | – |
| Hb (M: 13.4–17.5 g/dL F: 11.6–16.4 g/dL) | 14.9 (1.5) [12.3–16.4] {100.0} | 12.7 (3.2) [4.6–18.5] {71.4} | 9.8 (3.3) [4.1–16.7] {25.0} | 0.0008 | – | Yes | Yes |
| Hct (M: 0.4–0.5 L/L F: 0.3–0.5 L/L) | 0.5 (0.1) [0.4–0.5] {80.0} | 0.4 (0.1) [0.2–0.6] {77.1} | 0.3 (0.1) [0.2–0.5] {33.3} | 0.0004 | Yes | Yes | Yes |
| MCV (M: 83.1–101.6fL F: 78.9–98.5fL) | 90.6 (9.4) [74–108.2] {80.0} | 89.8 (7.9) [57.7–102.8] {85.7} | 84.6 (11.2) [63.1–103.6] {75.0} | 0.183 | – | – | – |
| MCH (M: 27.8–34.8 pg F: 26.1–33.5 pg) | 28.5 (2.8) [21.6–32.5] {70.0} | 29.1 (3.7) [15.3–36] {82.9} | 25.7 (5.1) [15.5–33.5] {66.7} | 0.047 | – | – | Yes |
| MCHC (M: 33–35 g/dL F: 32.7–34.9 g/dL) | 31.5 (1.5) [29.2–33.8] {70.0} | 32.2 (2.2) [26.2–35.5] {45.7} | 30.3 (3.0) [23.3–33.3] {33.3} | 0.038 | – | – | Yes |
| RCDW (M: 12.1–16.3% F: 12.4–17.3%) | 14.4 (1.6) [12.6–16.9] {90.0} | 15.0 (2.4) [11.9–22.1] {82.9} | 16.8 (3.1) [12.1–22.8] {58.3} | 0.040 | – | – | – |
| Plt (M: 171–388 × 109/L F: 186–454 × 109/L) | 232.9 (35.8) [169–296] {90.0} | 287.2 (128.2) [36–7] {71.4} | 358.6 (182.5) [149–796] {58.3} | 0.087 | – | – | – |
| MPV (M: 7.1–11.0 fL F: 7.3–11.3 fL) | 8.978 (1.2) [6.9–10.3] {88.9} | 8.8 (1.1) [7.1–11.4] {94.3} | 9.0 (0.9) [7.9–10.8] {100.0} | 0.779 | – | – | – |